Algo version: 0.98b
SLXN is listed at the NASDAQ Exchange
SLXN [SLXN]
NASDAQ Sector: Healthcare Industry:Biotechnology

Is SLXN stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

We cannot find any recorded dividends paid in our systems.

Sorry, we do not have any analyst data for this ticker

We cannot find data for Biomotion Sciences 10 years ago, but if you had invested on Monday 30th of October 2023 when the price was $10.87, you would have made a loss of $-10.54 per share or -96.94%

Yes, the average daily trading liquidity for Biomotion Sciences is $2.14 million. You should therefore be able to get in and out of your positions relatively fast.

Biomotion Sciences has N/A of the business financed by loans. This puts the company at N/A risk in periods of high inflation where borrowing costs usually go up. With a N/A cash flow to debt ratio of 0, the company's ability to pay off the debt is N/A. The company is still not profitable, and high inflation will make it harder to become profitable as costs increase and consumer spending decreases.

We have calculated the inflation risk for Biomotion Sciences to be low [0 out of 1]